Matthew K. Fust

CNS pipeline · person

Matthew K. Fust, MBA

Member of Neumora's Board of Directors since 2020. He formerly served as executive vice president and chief financial officer of Onyx Pharmaceuticals and as CFO of Jazz Pharmaceuticals, and currently serves on the boards of Atara Biotherapeutics, Crinetics Pharmaceuticals and Ultragenyx.

  • 1 company

Courtesy Neumora Therapeutics

Current roles

Appears with

People sharing a company with Matthew.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.